TGA
CARM

TPG GP A’s Carisma Therapeutics CARM Stock Holding History

TPG GP A’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-561,442
Closed -$551K – 33
2024
Q3 		$551K Sell
561,442
-280,589
-33% -$304K 0.01% 35
2024
Q2 		$1.28M Sell
842,031
-609,850
-42% -$910K 0.02% 32
2024
Q1 		$3.3M Sell
1,451,881
-232,181
-14% -$558K 0.06% 32
2023
Q4 		$4.93M Hold
1,684,062
– – 0.08% 34
2023
Q3 		$7.12M Hold
1,684,062
– – 0.12% 34
2023
Q2 		$14.8M Hold
1,684,062
– – 0.22% 34
2023
Q1 		$5.22M Buy
+1,684,062
New +$16M 0.09% 35

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return